Bladder Carcinoma Samples
86 Products
Human Serum - C68.0
- Donor:
- Gender: Female Age: 87
- Diagnosed disease:
- C68.0 - Malignant neoplasm of urethra
- Parameter:
- Anti-Glutamate Decarboxylase (GAD) Anti-Protein Tyrosine Phosphatase-like Protein IA-2 Antibodies (IA-2)
Donor:
- Gender:
- Female
- Age:
- 87 Years
Sample:
- Matrix:
- Serum
- Condition:
- perfect
- Stored at:
- < -18 degrees Celsius
- Freeze-Thaw-Cycle:
- 0
Diseases:
- Malignant neoplasm of urethra [C68.0]
| Parameter | Result | Ref. / Cut-Off | Measuring Information |
|---|---|---|---|
| Anti-Glutamate Decarboxylase (GAD) |
Qual: negative
Quant: < 5.00 IU/mL
Source: this donation
|
< 10.00 IU/mL
|
Method: EIA (Enzyme Immuno Assay) System: Euroimmun Analyzer EUROIMMUN AG |
| Anti-Protein Tyrosine Phosphatase-like Protein IA-2 Antibodies (IA-2) |
Qual: negative
Quant: < 10.00 IU/mL
Source: this donation
|
< 10.00 IU/mL
|
Method: EIA (Enzyme Immuno Assay) System: not specified not specified |
Disclaimer
- All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
- Molecular genetic tests that establish the donor's identity are prohibited.
- Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
- An import permit for biological substances may be required, in which case it must be present for purchase.
CBH296959
1 mL (€50.00)
Human Serum - Lactate dehydrogenase (LDH) - C67.8
- Donor:
- Gender: Female Age: 53
- Diagnosed disease:
- C67.8 - Malignant neoplasm of overlapping lesion of bladder
- Parameter:
- Lactate dehydrogenase (LDH)
Donor:
- Gender:
- Female
- Age:
- 53 Years
Sample:
- Matrix:
- Serum
- Condition:
- perfect
- Stored at:
- < -18 degrees Celsius
- Freeze-Thaw-Cycle:
- 0
Preanalytics:
- Details:
- centrifugation (10 min, 2500 x g = 3255 rpm, 20°C)
Diseases:
- Malignant neoplasm of overlapping lesion of bladder [C67.8]
| Parameter | Result | Ref. / Cut-Off | Measuring Information |
|---|---|---|---|
| Lactate dehydrogenase (LDH) |
Qual: positive
Quant: 5.37 µmol/s/L
Source: this donation
|
< 4.16 µmol/s/L
|
Method: Photometry System: cobas Roche |
Disclaimer
- All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
- Molecular genetic tests that establish the donor's identity are prohibited.
- Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
- An import permit for biological substances may be required, in which case it must be present for purchase.
CBH167207
0.5 mL (€81.25)
Human Serum - C67.8
- Donor:
- Gender: Male Age: 64
- Diagnosed disease:
- C67.8 - Malignant neoplasm of overlapping lesion of bladder
- Parameter:
- Prostate specific antigen (PSA), total
Donor:
- Gender:
- Male
- Age:
- 64 Years
Sample:
- Matrix:
- Serum
- Condition:
- perfect
- Stored at:
- < -18 degrees Celsius
- Freeze-Thaw-Cycle:
- 0
Preanalytics:
- Details:
- centrifugation (10 min, 2500 x g = 3255 rpm, 20°C)
Diseases:
- Malignant neoplasm of overlapping lesion of bladder [C67.8]
| Parameter | Result | Ref. / Cut-Off | Measuring Information |
|---|---|---|---|
| Prostate specific antigen (PSA), total |
Qual: negative
Quant: 1.92 ng/mL
Source: this donation
|
< 4.4 ng/mL
|
Method: ECLIA (Electro Chemiluminescence Immuno Assay) System: cobas Roche |
Disclaimer
- All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
- Molecular genetic tests that establish the donor's identity are prohibited.
- Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
- An import permit for biological substances may be required, in which case it must be present for purchase.
CBH167278
0.5 mL (€81.25)
Human Serum - C67.8
- Donor:
- Gender: Male Age: 74
- Diagnosed disease:
- C67.8 - Malignant neoplasm of overlapping lesion of bladder
- Parameter:
- Prostate specific antigen (PSA), total
Donor:
- Gender:
- Male
- Age:
- 74 Years
Sample:
- Matrix:
- Serum
- Condition:
- perfect
- Stored at:
- < -18 degrees Celsius
- Freeze-Thaw-Cycle:
- 0
Preanalytics:
- Details:
- centrifugation (10 min, 2500 x g = 3255 rpm, 20°C)
Diseases:
- Malignant neoplasm of overlapping lesion of bladder [C67.8]
| Parameter | Result | Ref. / Cut-Off | Measuring Information |
|---|---|---|---|
| Prostate specific antigen (PSA), total |
Qual: negative
Quant: 0.34 ng/mL
Source: this donation
|
< 4.4 ng/mL
|
Method: ECLIA (Electro Chemiluminescence Immuno Assay) System: cobas Roche |
Disclaimer
- All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
- Molecular genetic tests that establish the donor's identity are prohibited.
- Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
- An import permit for biological substances may be required, in which case it must be present for purchase.
CBH167273
0.5 mL (€81.25)
Human Serum - C67.8
- Donor:
- Gender: Male Age: 71
- Diagnosed disease:
- C67.8 - Malignant neoplasm of overlapping lesion of bladder
- Parameter:
- Prostate specific antigen (PSA), total
Donor:
- Gender:
- Male
- Age:
- 71 Years
Sample:
- Matrix:
- Serum
- Condition:
- perfect
- Stored at:
- < -18 degrees Celsius
- Freeze-Thaw-Cycle:
- 0
Preanalytics:
- Details:
- centrifugation (10 min, 2500 x g = 3255 rpm, 20°C)
Diseases:
- Malignant neoplasm of overlapping lesion of bladder [C67.8]
| Parameter | Result | Ref. / Cut-Off | Measuring Information |
|---|---|---|---|
| Prostate specific antigen (PSA), total |
Qual: negative
Quant: 1.51 ng/mL
Source: this donation
|
< 4.4 ng/mL
|
Method: ECLIA (Electro Chemiluminescence Immuno Assay) System: cobas Roche |
Disclaimer
- All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
- Molecular genetic tests that establish the donor's identity are prohibited.
- Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
- An import permit for biological substances may be required, in which case it must be present for purchase.
CBH167268
0.5 mL (€81.25)
Human Serum - C67.8
- Donor:
- Gender: Male Age: 81
- Diagnosed disease:
- C67.8 - Malignant neoplasm of overlapping lesion of bladder
- Parameter:
- Prostate specific antigen (PSA), total
Donor:
- Gender:
- Male
- Age:
- 81 Years
Sample:
- Matrix:
- Serum
- Condition:
- perfect
- Stored at:
- < -18 degrees Celsius
- Freeze-Thaw-Cycle:
- 0
Preanalytics:
- Details:
- centrifugation (10 min, 2500 x g = 3255 rpm, 20°C)
Diseases:
- Malignant neoplasm of overlapping lesion of bladder [C67.8]
| Parameter | Result | Ref. / Cut-Off | Measuring Information |
|---|---|---|---|
| Prostate specific antigen (PSA), total |
Qual: negative
Quant: 1.42 ng/mL
Source: this donation
|
< 4.4 ng/mL
|
Method: ECLIA (Electro Chemiluminescence Immuno Assay) System: cobas Roche |
Disclaimer
- All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
- Molecular genetic tests that establish the donor's identity are prohibited.
- Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
- An import permit for biological substances may be required, in which case it must be present for purchase.
CBH167259
0.6 mL (€97.50)
Human Serum - Procalcitonin (PCT) - C68.0
- Donor:
- Gender: Male Age: 58
- Diagnosed disease:
- C68.0 - Malignant neoplasm of urethra
- Parameter:
- Procalcitonin (PCT)
Donor:
- Gender:
- Male
- Age:
- 58 Years
Sample:
- Matrix:
- Serum
- Condition:
- perfect
- Stored at:
- < -18 degrees Celsius
- Freeze-Thaw-Cycle:
- 0
Diseases:
- Malignant neoplasm of urethra [C68.0]
| Parameter | Result | Ref. / Cut-Off | Measuring Information |
|---|---|---|---|
| Procalcitonin (PCT) |
Qual: positive
Quant: 4.16 ng/mL
Source: this donation
|
< 0.50 ng/mL
|
Method: ECLIA (Electro Chemiluminescence Immuno Assay) System: cobas 8000 / e 801 Roche Measured in: serum |
Disclaimer
- All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
- Molecular genetic tests that establish the donor's identity are prohibited.
- Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
- An import permit for biological substances may be required, in which case it must be present for purchase.
CBH302663
0.5 mL (€18.75)
Human Serum - Procalcitonin (PCT) - C67.2
- Donor:
- Gender: Male Age: 79
- Diagnosed disease:
- C67.2 - Malignant neoplasm of lateral wall of bladder
- Parameter:
- Procalcitonin (PCT)
Donor:
- Gender:
- Male
- Age:
- 79 Years
Sample:
- Matrix:
- Serum
- Condition:
- perfect
- Stored at:
- < -18 degrees Celsius
- Freeze-Thaw-Cycle:
- 0
Diseases:
- Malignant neoplasm of lateral wall of bladder [C67.2]
| Parameter | Result | Ref. / Cut-Off | Measuring Information |
|---|---|---|---|
| Procalcitonin (PCT) |
Qual: positive
Quant: 1.57 ng/mL
Source: this donation
|
< 0.50 ng/mL
|
Method: ECLIA (Electro Chemiluminescence Immuno Assay) System: cobas 8000 / e 801 Roche Measured in: serum |
Disclaimer
- All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
- Molecular genetic tests that establish the donor's identity are prohibited.
- Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
- An import permit for biological substances may be required, in which case it must be present for purchase.
CBH302788
0.5 mL (€18.75)
Human Serum - Procalcitonin (PCT) - C67.8
- Donor:
- Gender: Male Age: 74
- Diagnosed disease:
- C67.8 - Malignant neoplasm of overlapping lesion of bladder
- Parameter:
- Procalcitonin (PCT)
Donor:
- Gender:
- Male
- Age:
- 74 Years
Sample:
- Matrix:
- Serum
- Condition:
- perfect
- Stored at:
- < -18 degrees Celsius
- Freeze-Thaw-Cycle:
- 0
Diseases:
- Malignant neoplasm of overlapping lesion of bladder [C67.8]
| Parameter | Result | Ref. / Cut-Off | Measuring Information |
|---|---|---|---|
| Procalcitonin (PCT) |
Qual: positive
Quant: 0.51 ng/mL
Source: this donation
|
< 0.50 ng/mL
|
Method: ECLIA (Electro Chemiluminescence Immuno Assay) System: cobas 8000 / e 801 Roche Measured in: serum |
Disclaimer
- All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
- Molecular genetic tests that establish the donor's identity are prohibited.
- Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
- An import permit for biological substances may be required, in which case it must be present for purchase.
CBH302575
0.5 mL (€18.75)
Human Serum - Procalcitonin (PCT) - C67.2
- Donor:
- Gender: Male Age: 68
- Diagnosed disease:
- C67.2 - Malignant neoplasm of lateral wall of bladder
- Parameter:
- Procalcitonin (PCT)
Donor:
- Gender:
- Male
- Age:
- 68 Years
Sample:
- Matrix:
- Serum
- Condition:
- perfect
- Stored at:
- < -18 degrees Celsius
- Freeze-Thaw-Cycle:
- 0
Diseases:
- Malignant neoplasm of lateral wall of bladder [C67.2]
| Parameter | Result | Ref. / Cut-Off | Measuring Information |
|---|---|---|---|
| Procalcitonin (PCT) |
Qual: positive
Quant: 2.56 ng/mL
Source: this donation
|
< 0.50 ng/mL
|
Method: ECLIA (Electro Chemiluminescence Immuno Assay) System: cobas 8000 / e 801 Roche Measured in: serum |
Disclaimer
- All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
- Molecular genetic tests that establish the donor's identity are prohibited.
- Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
- An import permit for biological substances may be required, in which case it must be present for purchase.
CBH302531
0.6 mL (€22.50)
Human Serum - Procalcitonin (PCT) - C67.2
- Donor:
- Gender: Male Age: 68
- Diagnosed disease:
- C67.2 - Malignant neoplasm of lateral wall of bladder
- Parameter:
- Procalcitonin (PCT)
Donor:
- Gender:
- Male
- Age:
- 68 Years
Sample:
- Matrix:
- Serum
- Condition:
- perfect
- Stored at:
- < -18 degrees Celsius
- Freeze-Thaw-Cycle:
- 0
Diseases:
- Malignant neoplasm of lateral wall of bladder [C67.2]
| Parameter | Result | Ref. / Cut-Off | Measuring Information |
|---|---|---|---|
| Procalcitonin (PCT) |
Qual: positive
Quant: 1.54 ng/mL
Source: this donation
|
< 0.50 ng/mL
|
Method: ECLIA (Electro Chemiluminescence Immuno Assay) System: cobas 8000 / e 801 Roche Measured in: serum |
Disclaimer
- All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
- Molecular genetic tests that establish the donor's identity are prohibited.
- Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
- An import permit for biological substances may be required, in which case it must be present for purchase.
CBH302534
0.6 mL (€22.50)
Human Serum - Procalcitonin (PCT) - C67.2
- Donor:
- Gender: Male Age: 68
- Diagnosed disease:
- C67.2 - Malignant neoplasm of lateral wall of bladder
- Parameter:
- Procalcitonin (PCT)
Donor:
- Gender:
- Male
- Age:
- 68 Years
Sample:
- Matrix:
- Serum
- Condition:
- perfect
- Stored at:
- < -18 degrees Celsius
- Freeze-Thaw-Cycle:
- 0
Diseases:
- Malignant neoplasm of lateral wall of bladder [C67.2]
| Parameter | Result | Ref. / Cut-Off | Measuring Information |
|---|---|---|---|
| Procalcitonin (PCT) |
Qual: positive
Quant: 4.99 ng/mL
Source: this donation
|
< 0.50 ng/mL
|
Method: ECLIA (Electro Chemiluminescence Immuno Assay) System: cobas 8000 / e 801 Roche Measured in: serum |
Disclaimer
- All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
- Molecular genetic tests that establish the donor's identity are prohibited.
- Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
- An import permit for biological substances may be required, in which case it must be present for purchase.
CBH302525
0.6 mL (€22.50)
Human Serum - Procalcitonin (PCT) - C67.8
- Donor:
- Gender: Male Age: 73
- Diagnosed disease:
- C67.8 - Malignant neoplasm of overlapping lesion of bladder
- Parameter:
- Procalcitonin (PCT)
Donor:
- Gender:
- Male
- Age:
- 73 Years
Sample:
- Matrix:
- Serum
- Condition:
- perfect
- Stored at:
- < -18 degrees Celsius
- Freeze-Thaw-Cycle:
- 0
Diseases:
- Malignant neoplasm of overlapping lesion of bladder [C67.8]
| Parameter | Result | Ref. / Cut-Off | Measuring Information |
|---|---|---|---|
| Procalcitonin (PCT) |
Qual: positive
Quant: 3.41 ng/mL
Source: this donation
|
< 0.50 ng/mL
|
Method: ECLIA (Electro Chemiluminescence Immuno Assay) System: cobas 8000 / e 801 Roche Measured in: serum |
Disclaimer
- All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
- Molecular genetic tests that establish the donor's identity are prohibited.
- Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
- An import permit for biological substances may be required, in which case it must be present for purchase.
CBH302483
0.6 mL (€22.50)
Human Serum - Procalcitonin (PCT) - C67.8
- Donor:
- Gender: Male Age: 74
- Diagnosed disease:
- C67.8 - Malignant neoplasm of overlapping lesion of bladder
- Parameter:
- Procalcitonin (PCT)
Donor:
- Gender:
- Male
- Age:
- 74 Years
Sample:
- Matrix:
- Serum
- Condition:
- perfect
- Stored at:
- < -18 degrees Celsius
- Freeze-Thaw-Cycle:
- 0
Diseases:
- Malignant neoplasm of overlapping lesion of bladder [C67.8]
| Parameter | Result | Ref. / Cut-Off | Measuring Information |
|---|---|---|---|
| Procalcitonin (PCT) |
Qual: positive
Quant: 0.61 ng/mL
Source: this donation
|
< 0.50 ng/mL
|
Method: ECLIA (Electro Chemiluminescence Immuno Assay) System: cobas 8000 / e 801 Roche Measured in: serum |
Disclaimer
- All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
- Molecular genetic tests that establish the donor's identity are prohibited.
- Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
- An import permit for biological substances may be required, in which case it must be present for purchase.
CBH302566
0.6 mL (€22.50)
Human Serum - Procalcitonin (PCT) - C68.9
- Donor:
- Gender: Male Age: 74
- Diagnosed disease:
- C68.9 - Malignant neoplasm of urinary organ, unspecified
- Parameter:
- Procalcitonin (PCT)
Donor:
- Gender:
- Male
- Age:
- 74 Years
Sample:
- Matrix:
- Serum
- Condition:
- icteric
- Stored at:
- < -18 degrees Celsius
- Freeze-Thaw-Cycle:
- 0
Diseases:
- Malignant neoplasm of urinary organ, unspecified [C68.9]
| Parameter | Result | Ref. / Cut-Off | Measuring Information |
|---|---|---|---|
| Procalcitonin (PCT) |
Qual: positive
Quant: 1.28 ng/mL
Source: this donation
|
< 0.50 ng/mL
|
Method: ECLIA (Electro Chemiluminescence Immuno Assay) System: cobas 8000 / e 801 Roche Measured in: serum |
Disclaimer
- All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
- Molecular genetic tests that establish the donor's identity are prohibited.
- Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
- An import permit for biological substances may be required, in which case it must be present for purchase.
CBH302962
0.6 mL (€22.50)
Human Serum - Procalcitonin (PCT) - C67.8
- Donor:
- Gender: Male Age: 55
- Diagnosed disease:
- C67.8 - Malignant neoplasm of overlapping lesion of bladder
- Parameter:
- Procalcitonin (PCT)
Donor:
- Gender:
- Male
- Age:
- 55 Years
Sample:
- Matrix:
- Serum
- Condition:
- perfect
- Stored at:
- < -18 degrees Celsius
- Freeze-Thaw-Cycle:
- 0
Diseases:
- Malignant neoplasm of overlapping lesion of bladder [C67.8]
| Parameter | Result | Ref. / Cut-Off | Measuring Information |
|---|---|---|---|
| Procalcitonin (PCT) |
Qual: positive
Quant: 1.00 ng/mL
Source: this donation
|
< 0.50 ng/mL
|
Method: ECLIA (Electro Chemiluminescence Immuno Assay) System: cobas 8000 / e 801 Roche Measured in: serum |
Disclaimer
- All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
- Molecular genetic tests that establish the donor's identity are prohibited.
- Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
- An import permit for biological substances may be required, in which case it must be present for purchase.
CBH302726
0.6 mL (€22.50)
Human Serum - Procalcitonin (PCT) - C67.2
- Donor:
- Gender: Male Age: 68
- Diagnosed disease:
- C67.2 - Malignant neoplasm of lateral wall of bladder
- Parameter:
- Procalcitonin (PCT)
Donor:
- Gender:
- Male
- Age:
- 68 Years
Sample:
- Matrix:
- Serum
- Condition:
- perfect
- Stored at:
- < -18 degrees Celsius
- Freeze-Thaw-Cycle:
- 0
Diseases:
- Malignant neoplasm of lateral wall of bladder [C67.2]
| Parameter | Result | Ref. / Cut-Off | Measuring Information |
|---|---|---|---|
| Procalcitonin (PCT) |
Qual: positive
Quant: 1.07 ng/mL
Source: this donation
|
< 0.50 ng/mL
|
Method: ECLIA (Electro Chemiluminescence Immuno Assay) System: cobas 8000 / e 801 Roche Measured in: serum |
Disclaimer
- All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
- Molecular genetic tests that establish the donor's identity are prohibited.
- Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
- An import permit for biological substances may be required, in which case it must be present for purchase.
CBH302540
0.6 mL (€22.50)
Human Citrate plasma - D-Dimer - C67.8
- Donor:
- Gender: Male Age: 79
- Diagnosed disease:
- C67.8 - Malignant neoplasm of overlapping lesion of bladder
- Parameter:
- D-Dimer
Donor:
- Gender:
- Male
- Age:
- 79 Years
Sample:
- Matrix:
- Citrate plasma
- Condition:
- perfect
- Stored at:
- < -18 degrees Celsius
- Freeze-Thaw-Cycle:
- 0
Diseases:
- Malignant neoplasm of overlapping lesion of bladder [C67.8]
| Parameter | Result | Ref. / Cut-Off | Measuring Information |
|---|---|---|---|
| D-Dimer |
Qual: positive
Quant: 6.04 mg/l FEU
Source: this donation
|
< 0.49 mg/l FEU
|
Method: Turbidimetry System: STA-R Evolution Roche |
Disclaimer
- All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
- Molecular genetic tests that establish the donor's identity are prohibited.
- Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
- An import permit for biological substances may be required, in which case it must be present for purchase.
CBH176402
1.3 mL (€32.50)
Human K3EDTA plasma - Procalcitonin (PCT) - C67.8
- Donor:
- Gender: Male Age: 73
- Diagnosed disease:
- C67.8 - Malignant neoplasm of overlapping lesion of bladder
- Parameter:
- Procalcitonin (PCT)
Donor:
- Gender:
- Male
- Age:
- 73 Years
Sample:
- Matrix:
- K3EDTA plasma
- Condition:
- perfect
- Stored at:
- < -18 degrees Celsius
- Freeze-Thaw-Cycle:
- 0
Diseases:
- Malignant neoplasm of overlapping lesion of bladder [C67.8]
| Parameter | Result | Ref. / Cut-Off | Measuring Information |
|---|---|---|---|
| Procalcitonin (PCT) |
Qual: positive
Quant: 1.57 ng/mL
Source: this donation
|
< 0.50 ng/mL
|
Method: ECLIA (Electro Chemiluminescence Immuno Assay) System: cobas 8000 / e 801 Roche Measured in: serum |
Disclaimer
- All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
- Molecular genetic tests that establish the donor's identity are prohibited.
- Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
- An import permit for biological substances may be required, in which case it must be present for purchase.
CBH312470
0.9 mL (€33.75)
Human K3EDTA plasma - Procalcitonin (PCT) - C67.1
- Donor:
- Gender: Male Age: 82
- Diagnosed disease:
- C67.1 - Malignant neoplasm of dome of bladder
- Parameter:
- Procalcitonin (PCT)
Donor:
- Gender:
- Male
- Age:
- 82 Years
Sample:
- Matrix:
- K3EDTA plasma
- Condition:
- perfect
- Stored at:
- < -18 degrees Celsius
- Freeze-Thaw-Cycle:
- 0
Diseases:
- Malignant neoplasm of dome of bladder [C67.1]
| Parameter | Result | Ref. / Cut-Off | Measuring Information |
|---|---|---|---|
| Procalcitonin (PCT) |
Qual: positive
Quant: 0.58 ng/mL
Source: this donation
|
< 0.50 ng/mL
|
Method: ECLIA (Electro Chemiluminescence Immuno Assay) System: Kryptor Thermo Fisher (Brahms) Measured in: serum |
Disclaimer
- All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
- Molecular genetic tests that establish the donor's identity are prohibited.
- Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
- An import permit for biological substances may be required, in which case it must be present for purchase.
CBH107439
0.9 mL (€33.75)
Human K3EDTA plasma - Procalcitonin (PCT) - C67.1
- Donor:
- Gender: Male Age: 82
- Diagnosed disease:
- C67.1 - Malignant neoplasm of dome of bladder
- Parameter:
- Procalcitonin (PCT)
Donor:
- Gender:
- Male
- Age:
- 82 Years
Sample:
- Matrix:
- K3EDTA plasma
- Condition:
- perfect
- Stored at:
- < -18 degrees Celsius
- Freeze-Thaw-Cycle:
- 0
Diseases:
- Malignant neoplasm of dome of bladder [C67.1]
| Parameter | Result | Ref. / Cut-Off | Measuring Information |
|---|---|---|---|
| Procalcitonin (PCT) |
Qual: positive
Quant: 0.55 ng/mL
Source: this donation
|
< 0.50 ng/mL
|
Method: ECLIA (Electro Chemiluminescence Immuno Assay) System: Kryptor Thermo Fisher (Brahms) Measured in: serum |
Disclaimer
- All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
- Molecular genetic tests that establish the donor's identity are prohibited.
- Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
- An import permit for biological substances may be required, in which case it must be present for purchase.
CBH107474
0.9 mL (€33.75)
Human K3EDTA plasma - Procalcitonin (PCT) - C67.8
- Donor:
- Gender: Male Age: 67
- Diagnosed disease:
- C67.8 - Malignant neoplasm of overlapping lesion of bladder
- Parameter:
- Procalcitonin (PCT)
Donor:
- Gender:
- Male
- Age:
- 67 Years
Sample:
- Matrix:
- K3EDTA plasma
- Condition:
- perfect
- Stored at:
- < -18 degrees Celsius
- Freeze-Thaw-Cycle:
- 0
Diseases:
- Malignant neoplasm of overlapping lesion of bladder [C67.8]
| Parameter | Result | Ref. / Cut-Off | Measuring Information |
|---|---|---|---|
| Procalcitonin (PCT) |
Qual: positive
Quant: 1 ng/mL
Source: this donation
|
< 0.50 ng/mL
|
Method: ECLIA (Electro Chemiluminescence Immuno Assay) System: Kryptor Thermo Fisher (Brahms) Measured in: serum |
Disclaimer
- All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
- Molecular genetic tests that establish the donor's identity are prohibited.
- Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
- An import permit for biological substances may be required, in which case it must be present for purchase.
CBH107935
0.9 mL (€33.75)
Human K3EDTA plasma - Procalcitonin (PCT) - C67.8
- Donor:
- Gender: Male Age: 72
- Diagnosed disease:
- C67.8 - Malignant neoplasm of overlapping lesion of bladder
- Parameter:
- Procalcitonin (PCT)
Donor:
- Gender:
- Male
- Age:
- 72 Years
Sample:
- Matrix:
- K3EDTA plasma
- Condition:
- icteric
- Stored at:
- < -18 degrees Celsius
- Freeze-Thaw-Cycle:
- 0
Diseases:
- Malignant neoplasm of overlapping lesion of bladder [C67.8]
| Parameter | Result | Ref. / Cut-Off | Measuring Information |
|---|---|---|---|
| Procalcitonin (PCT) |
Qual: positive
Quant: 0.56 ng/mL
Source: this donation
|
< 0.50 ng/mL
|
Method: ECLIA (Electro Chemiluminescence Immuno Assay) System: cobas Roche Measured in: serum |
Disclaimer
- All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
- Molecular genetic tests that establish the donor's identity are prohibited.
- Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
- An import permit for biological substances may be required, in which case it must be present for purchase.
CBH94783
0.9 mL (€33.75)
Human K3EDTA plasma - Procalcitonin (PCT) - C67.8
- Donor:
- Gender: Male Age: 78
- Diagnosed disease:
- C67.8 - Malignant neoplasm of overlapping lesion of bladder
- Parameter:
- Procalcitonin (PCT)
Donor:
- Gender:
- Male
- Age:
- 78 Years
Sample:
- Matrix:
- K3EDTA plasma
- Condition:
- perfect
- Stored at:
- < -18 degrees Celsius
- Freeze-Thaw-Cycle:
- 0
Diseases:
- Malignant neoplasm of overlapping lesion of bladder [C67.8]
| Parameter | Result | Ref. / Cut-Off | Measuring Information |
|---|---|---|---|
| Procalcitonin (PCT) |
Qual: positive
Quant: 1.94 ng/mL
Source: this donation
|
< 0.50 ng/mL
|
Method: ECLIA (Electro Chemiluminescence Immuno Assay) System: cobas Roche Measured in: serum |
Disclaimer
- All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
- Molecular genetic tests that establish the donor's identity are prohibited.
- Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
- An import permit for biological substances may be required, in which case it must be present for purchase.
CBH156097
0.9 mL (€33.75)
Human K3EDTA plasma - Procalcitonin (PCT) - C67.8
- Donor:
- Gender: Male Age: 76
- Diagnosed disease:
- C67.8 - Malignant neoplasm of overlapping lesion of bladder
- Parameter:
- Procalcitonin (PCT)
Donor:
- Gender:
- Male
- Age:
- 76 Years
Sample:
- Matrix:
- K3EDTA plasma
- Condition:
- perfect
- Stored at:
- < -18 degrees Celsius
- Freeze-Thaw-Cycle:
- 0
Diseases:
- Malignant neoplasm of overlapping lesion of bladder [C67.8]
| Parameter | Result | Ref. / Cut-Off | Measuring Information |
|---|---|---|---|
| Procalcitonin (PCT) |
Qual: positive
Quant: 0.57 ng/mL
Source: this donation
|
< 0.50 ng/mL
|
Method: ECLIA (Electro Chemiluminescence Immuno Assay) System: cobas Roche Measured in: serum |
Disclaimer
- All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
- Molecular genetic tests that establish the donor's identity are prohibited.
- Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
- An import permit for biological substances may be required, in which case it must be present for purchase.
CBH156318
0.9 mL (€33.75)
Human K3EDTA plasma - Procalcitonin (PCT) - C67.8
- Donor:
- Gender: Male Age: 61
- Diagnosed disease:
- C67.8 - Malignant neoplasm of overlapping lesion of bladder
- Parameter:
- Procalcitonin (PCT)
Donor:
- Gender:
- Male
- Age:
- 61 Years
Sample:
- Matrix:
- K3EDTA plasma
- Condition:
- perfect
- Stored at:
- < -18 degrees Celsius
- Freeze-Thaw-Cycle:
- 0
Diseases:
- Malignant neoplasm of overlapping lesion of bladder [C67.8]
| Parameter | Result | Ref. / Cut-Off | Measuring Information |
|---|---|---|---|
| Procalcitonin (PCT) |
Qual: positive
Quant: 1.75 ng/mL
Source: this donation
|
< 0.50 ng/mL
|
Method: ECLIA (Electro Chemiluminescence Immuno Assay) System: cobas Roche Measured in: serum |
Disclaimer
- All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
- Molecular genetic tests that establish the donor's identity are prohibited.
- Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
- An import permit for biological substances may be required, in which case it must be present for purchase.
CBH163769
0.9 mL (€33.75)
Human K3EDTA plasma - Procalcitonin (PCT) - C67.8
- Donor:
- Gender: Female Age: 83
- Diagnosed disease:
- C67.8 - Malignant neoplasm of overlapping lesion of bladder
- Parameter:
- Procalcitonin (PCT)
Donor:
- Gender:
- Female
- Age:
- 83 Years
Sample:
- Matrix:
- K3EDTA plasma
- Condition:
- perfect
- Stored at:
- < -18 degrees Celsius
- Freeze-Thaw-Cycle:
- 0
Diseases:
- Malignant neoplasm of overlapping lesion of bladder [C67.8]
| Parameter | Result | Ref. / Cut-Off | Measuring Information |
|---|---|---|---|
| Procalcitonin (PCT) |
Qual: positive
Quant: 0.73 ng/mL
Source: this donation
|
< 0.50 ng/mL
|
Method: ECLIA (Electro Chemiluminescence Immuno Assay) System: cobas 8000 / e 801 Roche Measured in: serum |
Disclaimer
- All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
- Molecular genetic tests that establish the donor's identity are prohibited.
- Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
- An import permit for biological substances may be required, in which case it must be present for purchase.
CBH311575
0.9 mL (€33.75)
Human K3EDTA plasma - Procalcitonin (PCT) - C67.2
- Donor:
- Gender: Female Age: 84
- Diagnosed disease:
- C67.2 - Malignant neoplasm of lateral wall of bladder
- Parameter:
- Procalcitonin (PCT)
Donor:
- Gender:
- Female
- Age:
- 84 Years
Sample:
- Matrix:
- K3EDTA plasma
- Condition:
- perfect
- Stored at:
- < -18 degrees Celsius
- Freeze-Thaw-Cycle:
- 0
Diseases:
- Malignant neoplasm of lateral wall of bladder [C67.2]
| Parameter | Result | Ref. / Cut-Off | Measuring Information |
|---|---|---|---|
| Procalcitonin (PCT) |
Qual: positive
Quant: 0.69 ng/mL
Source: this donation
|
< 0.50 ng/mL
|
Method: ECLIA (Electro Chemiluminescence Immuno Assay) System: cobas 8000 / e 801 Roche Measured in: serum |
Disclaimer
- All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
- Molecular genetic tests that establish the donor's identity are prohibited.
- Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
- An import permit for biological substances may be required, in which case it must be present for purchase.
CBH311586
0.9 mL (€33.75)
Human EDTA plasma - Prostate specific antigen (PSA), total - C67.8
- Donor:
- Gender: Male Age: 66
- Diagnosed disease:
- C67.8 - Malignant neoplasm of overlapping lesion of bladder
- Parameter:
- Prostate specific antigen (PSA), total
Donor:
- Gender:
- Male
- Age:
- 66 Years
Sample:
- Matrix:
- EDTA plasma
- Condition:
- slightly hemolytic
- Stored at:
- < -18 degrees Celsius
- Freeze-Thaw-Cycle:
- 0
Diseases:
- Malignant neoplasm of overlapping lesion of bladder [C67.8]
| Parameter | Result | Ref. / Cut-Off | Measuring Information |
|---|---|---|---|
| Prostate specific antigen (PSA), total |
Qual: positive
Quant: 4.72 ng/mL
Source: this donation
|
< 4.40 ng/mL
|
Method: ECLIA (Electro Chemiluminescence Immuno Assay) System: cobas Roche |
Disclaimer
- All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
- Molecular genetic tests that establish the donor's identity are prohibited.
- Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
- An import permit for biological substances may be required, in which case it must be present for purchase.
CBH307596
0.5 mL (€37.50)
Human EDTA plasma - Prostate specific antigen (PSA), total - C67.8
- Donor:
- Gender: Male Age: 59
- Diagnosed disease:
- C67.8 - Malignant neoplasm of overlapping lesion of bladder
- Parameter:
- Prostate specific antigen (PSA), total
Donor:
- Gender:
- Male
- Age:
- 59 Years
Sample:
- Matrix:
- EDTA plasma
- Condition:
- perfect
- Stored at:
- < -18 degrees Celsius
- Freeze-Thaw-Cycle:
- 0
Diseases:
- Malignant neoplasm of overlapping lesion of bladder [C67.8]
| Parameter | Result | Ref. / Cut-Off | Measuring Information |
|---|---|---|---|
| Prostate specific antigen (PSA), total |
Qual: positive
Quant: 4.95 ng/mL
Source: this donation
|
< 4.40 ng/mL
|
Method: ECLIA (Electro Chemiluminescence Immuno Assay) System: cobas Roche |
Disclaimer
- All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
- Molecular genetic tests that establish the donor's identity are prohibited.
- Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
- An import permit for biological substances may be required, in which case it must be present for purchase.
CBH307606
0.5 mL (€37.50)
